(69 days)
Not Found
No
The summary describes "automated contour detection" and "automatically calculation" of parameters, which are typical image processing techniques, but there is no mention of AI, ML, or related terms like neural networks or deep learning. The description focuses on software functionality and data processing rather than learning algorithms.
No
The device is described as an analytical software tool for image analysis, used to support clinical diagnoses and decision-making, rather than directly treating a condition.
Yes
The document explicitly states that the device's intended purposes include "Supporting clinical diagnoses about stenosis and/or control of the placement of intervention devices" and that its parameters "may be useful in supporting the determination of a diagnosis." This indicates its role in aiding the diagnostic process.
Yes
The device is described as "analytical software tool designed for Windows NT operating systems" and its functionality is independent of the ultrasound equipment vendor. It facilitates the import and visualization of images and performs quantitative analysis. There is no mention of any accompanying hardware component being part of the device itself.
Based on the provided information, this device is not an IVD (In Vitro Diagnostic).
Here's why:
- IVD Definition: In vitro diagnostics are tests performed on samples taken from the human body, such as blood, urine, or tissue, to detect diseases, conditions, or infections.
- Device Function: The QCU-CMS device analyzes images (intravascular ultrasound and tomographic images) of the inside of blood vessels. It does not analyze biological samples taken from the patient.
- Intended Use: The intended use focuses on supporting clinical diagnoses and decision-making based on the analysis of these images, not on analyzing biological specimens.
Therefore, while it is a medical device used to aid in diagnosis and treatment decisions, it falls under the category of image analysis software rather than an in vitro diagnostic device.
N/A
Intended Use / Indications for Use
QCU has been developed for the objective and reproducible analysis of intravascular ultrasound images. Intended purposes are:
-
- Supporting clinical diagnoses about stenosis and/or control of the placement of intervention devices;
-
- Supporting subsequent clinical decision making purposes;
-
- Supporting the use in clinical research trials, directed at studying changes in vessel conditions over time as a result of interventions and or medication.
QCU has been developed for the objective and reproducible analysis of tomograhic images of both lumen and arterial wall of a coronary or vascular segment, in particular the assessment of a stenosis or atherosclerotic plaque. This information supports the the aboutinent of intervention devices in these vessels. QCU-CMS enables an advanced assessment of vessel, lumen, and stent morphology. It also avoids the very time-consuming conventional manual tracing of boundaries, which suffers from high intro- and inter observer variability. QCU-CMS can be used to control stent placement ind to assess in-stent restenosis. QCU software package enables the automatically calculation and the display of various parameters such as: areas and diameters in individual slices; volumes over the segment of interest (Simpson's Rule) for the vessel, lumen and stent contours; plaque and in-stent restenosis parameters.
QCU-CMS analytical software is intended to support all clinicians, i.e. cardiologists, radiologists, and referring physicians involved in the assessment of ultrasound images. radiological, and refering ped physician these parameters may be useful in supporting the determination of a diagnosis.
Product codes (comma separated list FDA assigned to the subject device)
90 LLZ, 90 IYO
Device Description
QCU-CMS is a state-of-the-art analytical software tool designed for Windows NT operating systems. QCU-CMS analytical software facilitates the import and visualization of ultrasound images via CD-ROM and digital network. The QCU-CMS functionality is independent of the ultrasound equipment vendor. QCU-CMS, using automated contour detection, provides quantitative analysis with objective and reproducible data of length and diameter, area and volume in regions of interest. The results of selected analysis can be reported in user-defined configuration, exported in general formats and transported for storage via communication with standard Microsoft office packages.
Mentions image processing
Yes
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Ultrasound images, tomograhic images
Anatomical Site
vessel, lumen, arterial wall of a coronary or vascular segment
Indicated Patient Age Range
Not Found
Intended User / Care Setting
cardiologists, radiologists, and referring physicians
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)
Not Found
Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)
Not Found
Predicate Device(s): If the device was cleared using the 510(k) pathway, identify the Predicate Device(s) K/DEN number used to claim substantial equivalence and list them here in a comma separated list exactly as they appear in the text. List the primary predicate first in the list.
Reference Device(s): Identify the Reference Device(s) K/DEN number and list them here in a comma separated list exactly as they appear in the text.
Not Found
Predetermined Change Control Plan (PCCP) - All Relevant Information for the subject device only (e.g. presence / absence, what scope was granted / cleared under the PCCP, any restrictions, etc).
Not Found
§ 892.2050 Medical image management and processing system.
(a)
Identification. A medical image management and processing system is a device that provides one or more capabilities relating to the review and digital processing of medical images for the purposes of interpretation by a trained practitioner of disease detection, diagnosis, or patient management. The software components may provide advanced or complex image processing functions for image manipulation, enhancement, or quantification that are intended for use in the interpretation and analysis of medical images. Advanced image manipulation functions may include image segmentation, multimodality image registration, or 3D visualization. Complex quantitative functions may include semi-automated measurements or time-series measurements.(b)
Classification. Class II (special controls; voluntary standards—Digital Imaging and Communications in Medicine (DICOM) Std., Joint Photographic Experts Group (JPEG) Std., Society of Motion Picture and Television Engineers (SMPTE) Test Pattern).
0
JUL 3 1 2001
6
QCUCMS 510(k) Premarket Notification
12 SUMMARY OF SAFETY AND EFFECTIVENESS: Submission in accordance with the requirements of 21 CFR Part 807.87(h)
: MEDIS medical imaging systems B.V. 1) Submitter : Poortgebouw Rijnsburgerweg 10 Address : 2333 AA Leiden : The Netherlands Telephone : + 31 71 5223244 : + 31 71 5215617 Fax Contact Person : May 21, 2001 Prepared 2) Device Name : QCU-CMS analytical software package
| 2) Device Name | : QCU-CMS analytical software package |
|---|---|
| Common Name | : QCU-CMS |
| Device Class. Name | : System, Image Processing |
| Regulation Number | : 21 CFR 892.1560 (90 LLZ; Class II) |
- : TomTec: 510(k) K993394 3) Predicate Device
4) Description of the device:
QCU-CMS is a state-of-the-art analytical software tool designed for Windows NT operating systems. QCU-CMS analytical software facilitates the import and visualization of ultrasound images via CD-ROM and digital network. The QCU-CMS functionality is independent of the ultrasound equipment vendor. QCU-CMS, using automated contour detection, provides quantitative analysis with objective and reproducible data of length and diameter, area and volume in regions of interest. The results of selected analysis can be reported in user-defined configuration, exported in general formats and transported for storage via communication with standard Microsoft office packages.
5) Intended use:
QCU has been developed for the objective and reproducible analysis of intravascular ultrasound images. Intended purposes are:
-
- Supporting clinical diagnoses about stenosis and/or control of the placement of intervention devices;
-
- Supporting subsequent clinical decision making purposes;
-
- Supporting the use in clinical research trials, directed at studying changes in vessel conditions over time as a result of interventions and or medication.
- Substantial equivalence Information:
The QCU-CMS software is substantially equivalent to the predicate devices of TomTec K993394 "Echo-Scan 4.x and Easy-Scan 1.x" by using the same technological characteristics and intended use.
1
CONCLUSIONS RESPECTING SAFETY and EFFECTIVINESS:
It is the opinion of MEDIS medical imaging systems B.V. that QCU-CMS is safe and it is the opinion of MED found by a risk management plan for the software potential nazards are oonlined by including hazard analysis (see Appendix D), development procode (600 Appendix E), Evaluation by hospitals and literature (see Appendix F) support this statement.
(See Appendix 1 ) Support this Statement.
In MEDIS' opinion the level of concern for the stand-alone software to view images is in MLDIS opinion the lever of ochoon for the stare does not change the intended use mindr and the use of &o- analytoar own the use of software result in any new potential hazards.
7
2
Image /page/2/Picture/1 description: The image shows the logo for the U.S. Department of Health & Human Services. The logo consists of a circular seal with the text "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" around the perimeter. Inside the circle is an abstract symbol resembling a stylized caduceus, with three wavy lines representing snakes intertwined around a staff.
Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850
JUL 3 1 2001
Re: K011582
OCU-CMS Analytical Software Dated: May 21, 2001 Received: May 23, 2001 Regulatory Class: II 21 CFR 892.2050/Procode: 90 LLZ 21 CFR 892.1560/Procode: 90 IYO
Dear Mr. Hollander:
Mr. J.I. Hollander
2333 AA Leiden
The Netherlands
Quality Coordinator
MEDIS Medical Imaging Systems B.V.
Poortgebouw, Rijnsburgerweg 10
We have reviewed your Section 510(k) notification of intent to market the device referenced above and we have determined the we have reviewed your Scholl 210x) notifications of muse stated in the enclosure) to legally marketed predicate devices device is substantaly courabile for the markent in the enactment date of the Medical Device Amendments, or to devices mat have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.
If your device is classified (see above) into either class III (Premarket Approval), it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, to such additional controls. Exisune mayor regulatent determination assumes compliance with the Current Good Manufacturing THE 21, Patis 800 00 072. A Substantian Ostan an Regulation (QS) for Medical Devices: General regulation (21 CFR Part Placice requirements, a scriour in the Quality of the Rog Administration (FDA) will verify such assumptions. Failure o comply with the GMP regulation may result in regulatory action. In addition, FDA may publish further announcements to concerning your device in the Federal Register. Please note: this response to your premarket notification submission does not concenting your device in the Feations 531 through 542 of the Act for devices under the Electronic Product Radiation Control provisions, or other Federal laws or regulations.
This letter will allow you to begin marketing your device as described in your 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801 and additionally 809.10 for in vitro 11 you done spontio davice to: Jose of Compliance at (301) 594-4639. Additionally, for questions on the promotion and advertising of your device, please contact the Office of Compliance at (301) 594-4639. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR 807.97). Other general information on your churces, "Misolanding of Televisor of Since the Division of Small Manufacturers Assistance at its toll-free number (800) 138-2041 or (301) 443-6597 or at its internet address "http://www.fda.gov/cdrh/dsma/dsmamain.html".
Sincerely vours
Nancy C. Brogdon
Nancy C. Brogdon Director, Division of Reproductive, Abdominal, and Radiological Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure (s)
3
510(k) NUMBER (IF KNOWN): K011582
DEVICE NAME: Geli Analytical Software Package
INDICATIONS FOR USE:
QCU has been developed for the objective and reproducible analysis of tomograhic images of both lumen and arterial wall of a coronary or vascular segment, in particular the assessment of a stenosis or atherosclerotic plaque. This information supports the the aboutinent of intervention devices in these vessels. QCU-CMS enables an advanced assessment of vessel, lumen, and stent morphology. It also avoids the very time-consuming conventional manual tracing of boundaries, which suffers from high intro- and inter observer variability. QCU-CMS can be used to control stent placement ind to assess in-stent restenosis. QCU software package enables the automatically calculation and the display of various parameters such as: areas and diameters in individual slices; volumes over the segment of interest (Simpson's Rule) for the vessel, lumen and stent contours; plaque and in-stent restenosis parameters.
QCU-CMS analytical software is intended to support all clinicians, i.e. cardiologists, radiologists, and referring physicians involved in the assessment of ultrasound images. radiological, and refering ped physician these parameters may be useful in supporting the determination of a diagnosis.
(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED.)
Concurrence of CDRH, Office of Device Evaluation (ODE)
ાર
Prescription Use (Per 21 CFR 801 109) Over - The - Counter - Use ef (Optional Format 1-
Nancy hogdon
[Division Ston-Off)
Division of Reproductive, Abdominal,
and Radiological Devices K011382
1510(k) Number